Abstract:The epidemiological and clinical burden of tricuspid regurgitation (TR) has lately gained much attention from the scientific community. In fact, recent epidemiological studies report a prevalence of moderate and severe TR in population over the age of 65 screened for valve disease ranging from 2.7% to 4%, with an independent prognostic role clearly worsening long-term survival along with the increasing severity of TR grade. Particularly, as TR is often clinically unsuspected until an advanced stage of congestive heart failure (HF), there is a great need of early diagnosis and long-term appropriate follow-up and management. Nonetheless, data focusing on the clinical and echocardiographic course of a cohort of patients suffering from moderate TR, although eagerly awaited, are lacking. To evaluate and clarify the evolution and the long-term independent clinical outcome of a cohort of patients suffering from moderate functional or organic TR. We electronically searched for ambulatory and in-patients who underwent transthoracic and/or transesophageal echocardiography with a diagnosis of moderate TR, along with a complete clinical evaluation, in our centre between January 2014 and December 2019. Patients were considered eligible if a second echocardiographic examination including a careful evaluation of the severity of TR and clinical information were available for a minimum follow-up of 6 months. The primary endpoint was all-cause mortality; secondary endpoints were hospitalization for HF and TV intervention, either surgical or percutaneous. We enrolled 130 patients, predominantly female with multiple comorbidities, cardiovascular risk factors and history of atrial fibrillation; TR aetiology was functional in most cases (93 patients, 72%). Over a mean follow-up of 5 years, TR grade progressed to at least severe in 55 patients (42%): at multivariate analyses, diabetes mellitus (P=0.003), anaemia (P=0.03) and at least moderate mitral regurgitation or aortic stenosis (P=0.039) were all predictors of TR severity progression. The primary endpoint occurred in 41(32%) of patients and was significantly more frequent (P<0.0001) in patients with severe TR at follow-up compared to those without TR severity progression. HF hospitalization and TV intervention occurred in 47 (36%) and 20 (14%) of patients: again, both were significantly more frequent in patients with severe TR (P=0.0008 and P=0.02, respectively) in comparison to those without worsened TR severity at follow-up. Our results show that moderate TR, over a long-term follow-up period, worsens to at least severe grade in a relevant proportion of patients, conveying a significant independent risk of hard events such as all-cause death, HF hospitalization and TV intervention. Therefore, this cohort of patients should be appropriately managed and closely followed-up in order to avoid adverse clinical events related to the natural course of this valvulopathy.

445 The long-term natural course of moderate tricuspid regurgitation

Tricuspid regurgitation in the context of severe left-sided valvular disease: Patients characteristics and outcome

Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study

Prognostic Impact and Late Evolution of Untreated Moderate (2/4+) Functional Tricuspid Regurgitation in Patients Undergoing Aortic Valve Replacement

Mild Tricuspid Regurgitation: A Marker of Disease Burden Independently Associated with Increased Mortality

39 Overview of tricuspid regurgitation (tr). new classification of tr. when severe tr is too severe?

Outcomes in severe tricuspid regurgitation by CMR: when severe is too severe

Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient‐level database analysis

New severity criteria for tricuspid regurgitation in a broad population of "real life" patients: prevalence and prognostic impact.

Impact of the new classification of tricuspid regurgitation on the baseline characteristics and prognosis of a wide series of "real life" patients

Tricuspid regurgitation and heart failure: the fate of treated vs. untreated cohort in the percutaneous era

Clinical and echocardiographic characterization of patients hospitalized for severe tricuspid valve regurgitation: a single tertiary-care center experience with 2-year follow-up

Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure

Tricuspid regurgitation and in-hospital outcomes after transcatheter aortic valve replacement in high-risk patients

Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Mitral Valve Replacement

Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome.

Tricuspid insufficiency: from anatomy to function

Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients

Evolution of Tricuspid Regurgitation after Mitral Valve Surgery for Patients with Moderate-Or-Less Functional Tricuspid Regurgitation

Etiology, epidemiology, pathophysiology and management of tricuspid regurgitation: an overview.

Tricuspid regurgitation in acute heart failure: is there any incremental risk?